LAG-3 in Cancer Immunotherapy
- 18 November 2010
- book chapter
- Published by Springer Nature
- Vol. 344, 269-278
Abstract
LAG-3 (CD223) is a cell surface molecule expressed on activated T cells (Huard et al. Immunogenetics 39:213–217, 1994 ), NK cells (Triebel et al. J Exp Med 171:1393–1405, 1990 ), B cells (Kisielow et al. Eur J Immunol 35:2081–2088, 2005 ), and plasmacytoid dendritic cells (Workman et al. J Immunol 182:1885–1891, 2009 ) that plays an important but incompletely understood role in the function of these lymphocyte subsets. In addition, the interaction between LAG-3 and its major ligand, Class II MHC, is thought to play a role in modulating dendritic cell function (Andreae et al. J Immunol 168:3874–3880, 2002 ). Recent preclinical studies have documented a role for LAG-3 in CD8 T cell exhaustion (Blackburn et al. Nat Immunol 10:29–37, 2009 ), and blockade of the LAG-3/Class II interaction using a LAG-3 Ig fusion protein is being evaluated in a number of clinical trials in cancer patients. In this review, we will first discuss the basic structural and functional biology of LAG-3, followed by a review of preclinical and clinical data pertinent to a role for LAG-3 in cancer immunotherapy.Keywords
This publication has 45 references indexed in Scilit:
- First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activityJournal of Translational Medicine, 2010
- Differential subcellular localization of the regulatory T‐cell protein LAG‐3 and the coreceptor CD4European Journal of Immunology, 2010
- Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancerProceedings of the National Academy of Sciences, 2010
- Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodiesJournal of Experimental Medicine, 2009
- Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T CellsThe Journal of Immunology, 2009
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infectionNature Immunology, 2008
- LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systemsJournal of Clinical Investigation, 2007
- Identification of a human CD8+regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4Proceedings of the National Academy of Sciences, 2007
- IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I studyJournal of Immune Based Therapies and Vaccines, 2007
- Metalloproteases regulate T‐cell proliferation and effector function via LAG‐3The EMBO Journal, 2007